Skip to main content

Frost Phillip MD Et Al's Form 4 filing

Opko Health, Inc. (OPK) ยท filed Mar 9, 2023

Accession no.
0001209191-23-017444
Filed
Mar 9, 2023, 6:26 AM ET
Trade date
Mar 8, 2023
Filing delay
1 day
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 24 non-derivative transactions. Open-market purchases total $1.18M. It was filed 1 day after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Frost Phillip MD Et AlCIK 0000898860Director, Officer (CEO & Chairman), 10% Owner
Frost Gamma Investments TrustCIK 000138089610% Owner

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Mar 8, 2023Common StockPPurchaseAcquired+300$1.12+$336198,831,994Indirect
Mar 8, 2023Common StockPPurchaseAcquired+39,028$1.13+$43,906.5198,871,022Indirect
Mar 8, 2023Common StockPPurchaseAcquired+22,049$1.13+$24,915.37198,893,071Indirect
Mar 8, 2023Common StockPPurchaseAcquired+5,700$1.13+$6,455.25198,898,771Indirect
Mar 8, 2023Common StockPPurchaseAcquired+107,200$1.14+$121,672199,005,971Indirect
Mar 8, 2023Common StockPPurchaseAcquired+348,101$1.14+$396,835.14199,354,072Indirect
Mar 8, 2023Common StockPPurchaseAcquired+13,569$1.15+$15,536.51199,367,641Indirect
Mar 8, 2023Common StockPPurchaseAcquired+1,900$1.15+$2,180.25199,369,541Indirect
Mar 8, 2023Common StockPPurchaseAcquired+81,336$1.15+$93,536.4199,450,877Indirect
Mar 8, 2023Common StockPPurchaseAcquired+1,000$1.15+$1,152.5199,451,877Indirect
Mar 8, 2023Common StockPPurchaseAcquired+59,117$1.16+$68,280.14199,510,994Indirect
Mar 8, 2023Common StockPPurchaseAcquired+20,700$1.16+$24,012199,531,694Indirect
Mar 8, 2023Common StockPPurchaseAcquired+7,958$1.23+$9,748.55199,539,652Indirect
Mar 8, 2023Common StockPPurchaseAcquired+15,386$1.23+$18,924.78199,555,038Indirect
Mar 8, 2023Common StockPPurchaseAcquired+1,200$1.24+$1,482199,556,238Indirect
Mar 8, 2023Common StockPPurchaseAcquired+11,556$1.24+$14,329.44199,567,794Indirect
Mar 8, 2023Common StockPPurchaseAcquired+11,300$1.25+$14,068.5199,579,094Indirect
Mar 8, 2023Common StockPPurchaseAcquired+92,000$1.25+$115,000199,671,094Indirect
Mar 8, 2023Common StockPPurchaseAcquired+89,710$1.26+$112,586.05199,760,804Indirect
Mar 8, 2023Common StockPPurchaseAcquired+2,700$1.26+$3,402199,763,504Indirect
Mar 8, 2023Common StockPPurchaseAcquired+7,341$1.27+$9,286.37199,770,845Indirect
Mar 8, 2023Common StockPPurchaseAcquired+34,812$1.27+$44,211.24199,805,657Indirect
Mar 8, 2023Common StockPPurchaseAcquired+6,037$1.28+$7,727.36199,811,694Indirect
Mar 8, 2023Common StockPPurchaseAcquired+20,000$1.29+$25,800199,831,694Indirect

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

No transaction price on this filing refers to a footnote.

Read the full filing on SEC EDGAR (opens in a new tab)